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3D cell tumour models are generated mainly in non-scalable culture systems, using bioactive scaffolds.
Many of these models fail to reﬂect the complex tumour microenvironment and do not allow long-term
monitoring of tumour progression. To overcome these limitations, we have combined alginate micro-
encapsulation with agitation-based culture systems, to recapitulate and monitor key aspects of the
tumour microenvironment and disease progression. Aggregates of MCF-7 breast cancer cells were
microencapsulated in alginate, either alone or in combination with human ﬁbroblasts, then cultured for
15 days. In co-cultures, the ﬁbroblasts arranged themselves around the tumour aggregates creating
distinct epithelial and stromal compartments. The presence of ﬁbroblasts resulted in secretion of pro-
inﬂammatory cytokines and deposition of collagen in the stromal compartment. Tumour cells estab-
lished cellecell contacts and polarised around small lumina in the interior of the aggregates. Over the
culture period, there was a reduction in oestrogen receptor and membranous E-cadherin alongside loss
of cell polarity, increased collective cell migration and enhanced angiogenic potential in co-cultures.
These phenotypic alterations, typical of advanced stages of cancer, were not observed in the mono-
cultures of MCF-7 cells. The proposed model system constitutes a new tool to study tumour-stroma
crosstalk, disease progression and drug resistance mechanisms.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The tumour microenvironment is composed of cancer cells, ﬁ-
broblasts, endothelial cells, immune cells and extracellular matrix
(ECM), whose interactions are critical for tumour initiation and
progression [1]. Tumour cells can induce a phenotypic change in
healthy ﬁbroblasts to become cancer associated ﬁbroblasts (CAFs)
with cancer-promoting properties such as secretion of matrix
components (collagen and ﬁbronectin), growth and inﬂammation1 Oeiras, Portugal.
Ltd. This is an open access article ufactors [1]. Abnormal deposition of collagen has been associated
with cancerous states due to increased matrix stiffness which is
known to contribute to tumour cell dissemination [2]. Additionally,
the activated stromal cells promote tumour progression by stimu-
lating cancer cell proliferation and migration, and ultimately
tumour metastasis [3]. Inﬁltrating stromal cells in the tumour are
the main providers of matrix metalloproteinases (MMPs) that,
through remodelling of ECM, release chemotactic agents and
loosen the matrix contributing to tumour cell dissemination [4].
These changes are responsible for the recruitment of immune cells
and for increasing chronic inﬂammation, which also contributes to
tumour aggressiveness [5].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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environment, many in vitro models have been developed in the
recent years [6]. In most of these models however, tumour cells are
grown as monotypic cultures in two-dimensions (2D). In 2D, cells
are not able to organize into tissue-like structures since they lack
the tridimensionality (3D) bestowed by the surrounding microen-
vironment [7]. In contrast, heterotypic tumour aggregate 3D cul-
tures enable tumour cells to establish cellecell and cell-ECM
interactions, which are important elements in tumour signalling
and which modulate tumour responses to therapeutic agents [8].
However, tumour aggregates are mostly cultured in low-adherence
conditions [9] or embedded in bioactive scaffolds such as collagen I
or matrigel [6]. These scaffolds also have limitations, including
batch-to-batch variation and an incomplete understanding of their
impact on cell behaviour [10,11]. In contrast, hydrogels such as
alginate present many advantages over bioactive scaffolds due to
their inert properties, biocompatible gelation and ease of cell re-
covery. Hydrogels also provide the possibility of conjugation with
deﬁned adhesion ligands or delivery of speciﬁc biomolecules
(growth factors, pro-angiogenic factors, amongst others) [12,13].
Alginates are polysaccharide hydrogels composed of b-D-man-
nuronic acid (M) and a-L-guluronic acid (G) obtained from partic-
ular brown algae species [13]. Alginate comprises 99% water, but
still retains high plasticity and mechanical strength. Gelling occurs
almost instantaneously by cross-linking with divalent ions, like
Ca2þ, allowing for cell entrapment under physiological conditions
and rapid cell recovery by gel dissolution [14]. Most cell lines are
able to grow in non-functionalized alginates, despite the absence of
cell adhesion sites [13]. Alginate microencapsulation has been used
to investigate the effect of biomechanical forces exerted on tumour
aggregates [15]. More recently, alginate microencapsulation and
microﬂuidic devices have been used to study the interaction be-
tween different cell types [11,16]. However, these models have been
generated in non-scalable culture systems, with no control of the
physicochemical parameters and which allow end-point analysis
only [17,18]. As a result, studies on the molecular mechanisms
behind disease progression and drug resistance as well as high-
throughput drug screening are performed in models that lack the
complexity of human tumours and which do not allow continuous
monitoring of the culture progression.
Herein, we describe a novel in vitro culture model system for
long-term co-culture of tumour and stromal cells, based on the
combination of alginate microencapsulation with suspension cul-
tures in agitation-based culture systems. We used alginate as a
scaffold for cell entrapment, not only due to its properties outlined
above, but also to provide physical support and cell conﬁnement, in
a manner compatible with stirred-tank systems. This strategy
provides a means of long-term culture of tumour cell aggregates
either alone or in combination with ﬁbroblasts, continuously
monitored with non-destructive sampling. The developed model
system can be transferred across several pathologies and will
provide a new tool for characterization of disease progression and
drug resistance mechanisms in vitro.
2. Materials and methods
2.1. 2D cell culture
MCF-7 cells transduced with the lentiviral vectors PGK-dsRED
and pCDH-CMV-MCS-EF1-Puro, were kindly provided by Profes-
sor Cathrin Brisken (EPFL, Switzerland) within the scope of the
PREDECT consortium. MCF-7 reporter cells were used as a com-
plementary tool for live monitoring purposes. Cell expansion was
performed in Dulbecco's Modiﬁed Eagle Medium (DMEM) with
25 mM Glucose, supplemented with 1% (v/v) penicillin-streptomycin, 4 mM Glutamax, 1 mM sodium pyruvate and 10%
(v/v) fetal bovine serum (FBS). Cells were passaged twice weekly at
a inoculum concentration of 1.5  104 cell/cm2. Human Dermal
Fibroblasts (HDF), from Innoprot, were passaged once weekly for
up to 10 to 12 passages at a seeding density of 0.5  104 cell/cm2, in
Iscove's Modiﬁed Dulbecco's Medium (IMDM) supplemented with
1% (v/v) penicillin-streptomycin and 10% (v/v) FBS (all from Life
Technologies). Both the MCF-7 cells and the HDFs were cultured in
static culture systems, in an incubator at 37 C with humidiﬁed
atmosphere containing 5% CO2 in air.
2.2. 3D cell culture
MCF-7 cells, non transduced and transduced with the lentiviral
vectors described above, were inoculated as single cell suspensions
(0.2  106 cell/mL) into 125 mL stirred-tank vessels with ﬂat cen-
tred cap and angled side arms (Corning e http://catalog2.corning.
com/LifeSciences/en-US/Shopping/ProductDetails.aspx?category
name¼&productid¼4500-125%28Lifesciences%29) and cultured at
80 rpm, to induce cell aggregation. For alginate microencapsula-
tion, tumour cell aggregates were collected from the stirred-tank
vessels after 24 h of culture. Aggregates corresponding to approx-
imately 25  106 tumour cells were dispersed in 3 mL of 1.1% (w/v)
of Ultrapure Ca2þ MVG alginate (UP MVG NovaMatrix, Pronova
Biomedical, Oslo, Norway) dissolved in NaCl 0.9% (w/v) solution
either alone (mono-cultures) or together with HDFs, in a 1:1 ratio
for approximately 50  106 total cells (co-cultures). Mono-cultures
of HDFs were also microencapsulated (25  106 total cells) and
used as controls. Microencapsulation was performed using an
electrostatic bead generator (Nisco VarV1, Zurich, Switzerland), to
produce beads of approximately 500 mm in diameter [19]. The
alginate droplets were cross-linked in a 100 mM CaCl2/10 mM
HEPES (pH 7.4) solution for 10 min, further washed three times in a
0.9% (w/v) NaCl solution and ﬁnally equilibrated in culture medium
before being transferred to stirred-tank vessels. The micro-
encapsulated mono and co-cultures were kept in 125 mL stirred-
tank vessels at 80 rpm, in a humidiﬁed incubator, with 5% CO2 in
air, for 15 days with 50% medium exchange every 3e4 days.
2.3. Cell viability
Cell viability was assessed using ﬂuorescein diacetate (FDA;
SigmaeAldrich) at 10 mg/mL to label live cells, and To-PRO-3 iodite
(LifeTechnologies) at 1 mM, for dead cells. Microencapsulated
tumour aggregates and ﬁbroblasts were incubated for 5 min at RT
with the labels then visualized using a ﬂuorescence microscope
(DMI6000, Leica Microsystems GmbH, Wetzlar, Germany) or a
spinning disk microscope (Andor Revolution Å~ D, Andor Tech-
nology PLC, Belfast, Northern Ireland).
2.4. Aggregate size
To measure aggregate size, alginate microcapsules were dis-
solved in a chelating solution (Sodium citrate 50 mM/Sodium
chloride 100mM), for 5 min at room temperature (RT), and washed
twice with Phosphate-Buffered Saline (PBS; Life Technologies).
Aggregates were imaged using a ﬂuorescence microscope
(DMI6000, Leica Microsystems GmbH, Wetzlar, Germany). Aggre-
gate surface area was quantiﬁed using FIJI open source software
(Rasband, WS, ImageJ, U. S. National Institutes of Health, Bethesda,
MD, USA, http://imagej.nih.gov/ij/, 1997e2012.), by applying auto-
mated threshold adjustment followed by the area measurement
algorithm.
Statistical analysis was carried out using GraphPad Prism 5
software. Data is presented as mean ± SD from three independent
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was used to compare aggregate surface area differences between
mono and co-cultures, at days 2, 5, 10 and 15.
2.5. Total cell concentration
To assess cell concentration, alginate microcapsules were ﬁrstly
dissolved, as described in the previous section. After dissolution of
alginate, aggregates were pelleted by centrifugation at 50x g for
5min at RT. Cells were lysedwith 0.1M of citric acid/1% (w/v) Triton
e X100 in water. After cell lysis, nuclei were stained with 0.1% (v/v)
Crystal Violet and counted in a Fuchs-Rosenthal haemacytometer
chamber, using a phase contrast microscope (DMIRB, Leica,
Germany).
Statistical analysis was carried out using GraphPad Prism 5
software. Data is presented as mean ± SD from four independent
experiments. A two way ANOVA statistics test of signiﬁcance was
used to compare tumour cell growth in mono and co-cultures over
time.
2.6. Immunoﬂuorescence (IF) microscopy and image analysis
Culture samples were collected at days 5 and 15 of culture and
ﬁxed in 4% (v/v) paraformaldehyde (PFA)/4% (v/v) Sucrose for
20 min. For cryosectioning samples were dehydrated with 30% (w/
v) sucrose overnight, frozen at 80 C in Tissue-Tek O.C.T. (Sakura,
Alphen aan den Rijn, Netherlands) and sectioned at a thickness of
10 mm using a cryomicrotome (Cryostat I, Leica, Wetslar, Germany).
Immunoﬂuorescence was performed according to previously
published methods [19,20]. In brief, cells were permeabilized with
0.1% Triton X-100 (w/v) (10 min for cryosections; 2 h for whole
aggregates) and blocked in 0.2% (w/v) Fish Skin Gelatin (FSG; Sig-
maeAldrich). Primary antibodies were diluted in 0.2% (w/v) FSG
and incubated for 2 h at RT and secondary antibodies diluted in
0.125% (w/v) FSG and incubated for 1 h at RT (Supplementary
Table 1). Samples were mounted in ProLong Gold Antifade
Mountant containing DAPI (Life Technologies) and visualized using
either a ﬂuorescence microscope (DMI6000, Leica Microsystems
GmbH, Wetzlar, Germany, a 2-photon microscope (Prairie TPE) or a
Light Sheet Microscope (SPIM-FLUID).
2.7. Image acquisition and analysis in SPIM-FLUID
In order to facilitate automated sample loading, we used a sys-
tem based on light-sheet ﬂuorescence microscopy (LSFM), SPIM-
Fluid [21]. Across a water ﬁlled chamber, at 45, a FEP tube posi-
tioned at the intersection of the illumination and detection focal
plane transports the samples, which can be aspired and pushed
back and forward with an Arduino controlled stepper motor
attached to a syringe (Eppendorf CellTram). Images are acquired
sequentially, as the samples cross the light-sheet plane. The illu-
mination block consists of a home-made laser combiner including
two laser lines: 473 nm (DPSSL MBL-III-473-50) and 561 nm
(Coherent OBIS 561-50 LS), selected using an Arduino controlled
ﬁlter wheel with two ﬁlters (Semrock 473/10, 561/10). Laser scan-
ning is carried out in the vertical axis using an Arduino controlled
galvanometric mirror (6210H Cambridge Technologies) in which
the optical plane is conjugated with the back focal aperture of an
objective lens (Plan Fluor 4  0.13 WD17.4 mm) using a
3.5  telescope system. For detection, an air objective (Nikon
10  0.3NAWD 16.7 mm), placed perpendicularly to the excitation
plane, is used to collect ﬂuorescence emission. Excitation light is
rejected using emission ﬁlters placed in inﬁnity space before the
camera. Finally a 200mm tube lens creates the image on the chip of
the sCMOS cameras (Hamamatsu Orca-Flash4).A controller for sample positioning and scanning allows micro-
steps up to 0.225, which translate into sample steps of 2 microns
(FEP tube of 1 mm inner diameter). To automatise the acquisition
process, we have designed a photometer using a photodiode to
detect sample passage. The system also permits control of a sec-
ondary camera, allowing fast two colour imaging. We have also
created a dedicated java Plugin for Micromanager acquisition
software [22], which enables easy control of sample positioning
and data acquisition from a single window, creating a modular
open source platform for high throughput screening on 3D cell
cultures.
After image acquisition, images were processed using a kit of
tools from FIJI image processing software [23]. In ﬁrst place, data
were sorted by image intensities in order to separate individual
capsules. Subsequently, images having 2 capsules were processed
with a different set of FIJI's tools to separate correctly the capsules
and different aggregates per capsule in order to accurately estimate
aggregate volume. Finally we used Image J plugins, such “3D Ob-
jects Counter”, “Analyze Particles” and “3D Manager”, to measure
aggregate volume, ﬁbroblast numbers and circularity.
2.8. Immunohistochemistry (IHC) and image analysis
Samples were collected and ﬁxed as described above. Aggre-
gates were pelleted, embedded in 1% (w/v) high melting temper-
ature agarose (Lonza), dehydrated in graded alcohols and then
embedded in parafﬁn wax. Parafﬁn blocks were sectioned (3 mm)
for Hematoxylin & Eosin and immunohistochemical staining.
Immunohistochemistry was carried out using standard protocols
[24]. Brieﬂy, antigen retrieval was performed using histoprocessing
modules (Milestone Medical) at 110 C under pressure, for 2 min,
using pH6 antigen retrieval solution (Dako). Staining was per-
formed using a Labvision Autostainer 720 (Thermo Scientiﬁc).
Stained slides were scanned using a ScanScope AT Turbo slide
scanner (Aperio) and images were analysed using Aperio image
analysis software (Aperio). Aperio image analysis software is able to
recognise either nuclear or membrane speciﬁc staining, and was
trained to discern between negative, weak, medium and strong
staining intensities.
Statistical analysis was carried out using GraphPad Prism 5
software. Data is presented as mean ± SD from more than 70 ag-
gregates. Two-way ANOVA statistics test was used to compare the
intensity of membranous E-cadherin and ER staining, in both mono
and co-cultures, at days 5 and 15 of culture.
2.9. Western Blot (WB)
Culture samples were collected and alginate microcapsules
dissolved, as described above in section 2.4. Following 2 steps of
aggregate washing, cell pellets were snap frozen and stored
at 80 C. For Western Blot analysis aggregates were lysed in Tx-
100 lysis buffer (50 mM Tris, 5 mM EDTA, 150 mM NaCl, 1% (w/v)
Triton X-100 and 1x (w/v) complete protease and phosphatase
inhibitor cocktail (Roche)). Protein quantiﬁcation was performed
using the Micro-BCA Protein Assay Kit (Thermo Scientiﬁc). Proteins
were denatured, loaded in an electrophoresis gel (NuPAGE 4e12%
BiseTris Gel) under reducing conditions for 40min (200 V, 400mA)
and then electrophoretically transferred to a polyvinylidene ﬂuo-
ride (PVDF) membrane (Millipore). Membranes were blocked for
1 h in PBS with 0.1% (w/v) Tween 20/5% (w/v) non-fat dried milk
powder and further incubated with the primary and secondary
antibodies. Anti-b tubulin was used as a loading control. Mem-
branes were developed using Amersham ECL Prime Western Blot
Detection Reagent (GE Healthcare) and visualized using a Chem-
iDocTM XRS þ System (BioRad). Chemiﬂuorescence was quantiﬁed
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Statistical analysis was carried out using GraphPad Prism 5
software. Data is presented as mean ± SD from three independent
experiments. Two-way ANOVA statistics test was used to compare
the average protein levels of ER, in both mono and co-cultures, at
days 5 and 15 of culture.
2.10. Collagen quantiﬁcation
Collagen was quantiﬁed in both alginate microcapsules and
culture supernatants, using the Sircol Collagen Colorimetric assay
kit (Biocolor Ltd., U.K.), according to the manufacturer's
instructions.
Statistical analysis was carried out using GraphPad Prism 5
software. Data is presented as mean ± SD from three independent
experiments. The non-parametric KruskaleWallis statistics test
was used to compare collagen concentration between mono and
co-cultures, at days 5 and 15.
2.11. Cytokine arrays
Culture samples were collected and alginate microcapsules
were pelleted by centrifugation at 50x g and dissolved as described
above. The microcapsule soluble fraction (MSF) was separated from
the cell fraction by centrifugation. Cells and cell debris were
removed from both culture supernatant (CS) and the MSF by
additional centrifugation at 300x g followed by 1000x g for 5 min at
4 C.
After concentration and buffer exchange of MSF to 1 mL, using
centrifugal ﬁlter units with a 3 kDa membrane cut off (Amicon,
Millipore), cytokine array analysis was performed using the Human
Cytokine Array, Panel A (R&D Systems; ARY005), according to the
manufacturer's instructions. Membranes were exposed to X-Ray
ﬁlms for 1, 5 and 10min. The developedﬁlmsweredigitalized at 600
dpi using LabScan 5 Software (AmershamBiosciences, Switzerland).
Spot analysis was performed using the Progenesis SameSpots soft-
ware, version 4.5 (NonLinear Dynamics, UK). All ﬁlms were quality
checked, aligned and spots were quantiﬁed based on the volume
and area of each spot. Relative secretion of each cytokine was
calculated according with the following equation [25]:
Relativesecretion %ð Þ¼Cytokinesecretionnegativecontrol
positivecontrolnegativecontrol 100%
Statistical analysis was carried out using GraphPad Prism 5
software. Data is presented as mean ± SD from two independent
experiments. The non-parametric Man-Whitney U statistics Test
(two-tailed p-value) was used to compare the cytokines present in
culture supernatant vs MSF and the differences between mono and
co-cultures; all comparisons were performed at days 5 and 15.
Microencapsulated mono-cultures of ﬁbroblasts were used as
controls.
2.12. Chicken embryo chorioallantoic membrane (CAM)
angiogenesis assay
The chicken embryo chorioallantoic membrane (CAM) assay
was used to evaluate the angiogenic response to tumour aggregates
frommono and co-cultures collected at day 15 of culture. Fertilized
chicken (gallus gallus) eggs, obtained from commercial sources,
were incubated horizontally at 37.8 C in a humidiﬁed atmosphere.
On embryonic day (E) 3 a square window was opened in the shell
after removal of 2e2.5 mL of albumen, to allow detachment of the
developing CAM. The window was sealed with adhesive tape and
the eggs returned to the incubator. To remove the ﬁbroblasts, ECMand soluble factors, alginate microcapsules were dissolved, as
described above, and tumour aggregates were washed twice with
PBS (Ca2þ/Mg2þ). Tumour aggregates were re-suspended in 10 ml of
medium and placed in a 3 mm silicone ring on the E10 growing
CAM (1  106 cell per embryo) under sterile conditions. The eggs
were re-sealed and returned to the incubator for 3 days. After
removing the ring, the CAM was excised from the embryos, pho-
tographed ex-ovo under a stereoscope, at 20x magniﬁcation
(Olympus, SZX16 coupled with a DP71 camera).
The number of new vessels (less than 15 mm in diameter)
growing radially towards the ring area, in which the cells had been
applied to the CAM, were counted blinded. Statistical analysis was
carried out using GraphPad Prism 5 software. Data is presented as
mean ± SD from 18 eggs. A t- Test (two-tailed p-value) was used to
test signiﬁcance.
3. Results
3.1. Alginate microencapsulation combined with stirred-tank
culture for long-term 3D heterotypic cell culture
To establish microencapsulated cultures, a dual step strategy in
a stirred-tank culture systemwas adopted (Fig. 1). In the ﬁrst stage,
tumour cells were inoculated as single cell suspensions and
cultured for 24 h to induce cell aggregation. Tumour aggregates
were then collected (see materials and methods for details) and
microencapsulated in alginate either alone (mono-culture) or
together with human ﬁbroblasts (tumour-stromal co-cultures), and
further cultured in stirred-tank vessels for up to 15 days (Fig. 1).
This strategy has been applied to both breast and lung cancer cell
lines. The ability to sample in a non-destructive manner, offered by
this system, allowed us to continuously monitor the culture pro-
gression and to take samples throughout the culture period
without sacriﬁcing the whole culture vessel. All cell types main-
tained viability throughout the duration of culture nonetheless cell
growth kinetics and aggregate morphology varied from cell line to
cell line. More speciﬁcally, whereas the MCF-7 breast cancer cell
line only presented a signiﬁcant increase in cell concentration
during the ﬁrst 6 days of culture, cell concentration of the lung
cancer cell line NCI-H157 continued to increase throughout the 15
days of culture (data not shown). ERþ breast cancers are described
to present high frequency of disease relapse associated with
metastasis and drug resistance, despite the initial response to
endocrine therapy [27,28]. MCF-7 cells, one of themost widely used
ERþ/PRþ cell lines [29] were chosen as the focus of Work Package 1
of the PREDECT consortium (www.predect.eu) and therefore were
used herein for characterization of our model system.
3.2. MCF-7 cell proliferation and partial polarisation, in
microencapsulated cultures
Live/dead assays showed MCF-7 aggregates with circular
morphology, deﬁned edges, high cell viability and the absence of
necrotic centres in both mono and co-cultures (Fig. 2A).
After an initial growth phase, up to day 6, MCF-7 cell number
reached a plateau that remained constant until day 15 of culture
(Fig. 2B). A slight increase in tumour cell concentration was
observed in co-cultures by day 15, but this was not statistically
signiﬁcant. Aggregates from both culture types (mono and co-
cultures) contained small lumina surrounded by polarised cells,
as shown by apical accumulation of f-actin and ZO-1 (Fig. 2C1 and
2C2), together with pyknotic nuclei within the lumens (Fig. 2C3).
Partial cell polarisation was seen at the outer rim of the aggregates
as indicated by ZO-1 apical accumulation. Tumour cells were also
cytokeratin 18 (CK18) positive, with localisation of E-cadherin
Fig. 1. Schematic illustration of the experimental approach e in vitro reconstruction of tumour microenvironment in stirred-tank culture systems. (A) MCF-7 cells were
aggregated in stirred-tank vessels for 24 h and then harvested and pelleted for further microencapsulation. (B) Tumour aggregates were microencapsulated in alginate alone
(tumour mono-cultures) or together with ﬁbroblasts (tumour e stromal co-cultures). (C) Microencapsulated cells were cultured in stirred-tank vessels for up to 15 days during
which culture characterization was carried out.
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in non-microencapsulated cultures, tumour cells did not polarise,
although cellecell adhesions through E-cadherin were formed and
CK18 expression was maintained (Figure S1). Additionally, prolif-
eration (Ki67) and apoptosis (as indicated by caspase cleaved CK18
or M30) markers showed that proliferating cells were distributed
homogeneously through the aggregates and that the number of
apoptotic cells was very low. No apoptotic cell centres were
detected in the aggregates. Overall, no phenotypic differences were
observed between microencapsulated mono and co-cultures, until
day 5 of culture.3.3. Cell organization and collagen accumulation in alginate
microcapsules resemble structures observed in human tumours
Immunoﬂuorescence analysis by Light Sheet Microscopy of
alginate microcapsules from co-cultures showed that ﬁbroblasts
were distributed around tumour aggregates (Fig. 3A), creating a
“stromal compartment”.
In non-microencapsulated cultures, ﬁbroblasts accumulated in
the centre of the aggregate [26]. Quantiﬁcation of the number of
ﬁbroblasts per microcapsule, demonstrated that the number of ﬁ-
broblasts was similar across microcapsules, that ﬁbroblast con-
centration remained constant throughout the culture time (Fig. 3B).
Vimentin and collagen (Type I and IV) expression was kept
throughout the culture time (data not shown).
A 1.5-fold increase in collagen concentration was found in co-
cultures at day 15 as compared to day 5. Furthermore, compari-
son of both types of culture revealed that the co-cultures had
accumulated signiﬁcantly higher levels of collagen than mono-
cultures by day 15 (Fig. 3D). Using whole mount immunoﬂuores-
cence of the microencapsulated co-cultures, we observed that
collagen I accumulated in the stromal compartment (Fig. 3C) and
assembled into ﬁbres (Fig. 3C1), as typically observed in tissues
[30].3.4. The effect of stroma on disease progression events can be
monitored and further investigated in long-term stirred-tank
cultures
At day 15, aggregates in co-cultures presented an altered
phenotype in that there was loss of aggregate circularity (Fig. 4A)
and unidirectional aggregate migration from the microcapsules
(Fig. 4B). Whilst in mono-cultures, 90% of the aggregates main-
tained the circularity observed at day 5 (95% in both cultures), inthe co-cultures, the aggregate population became very heteroge-
neous, with 40% of the aggregates presenting an altered shape
(Fig. 4A). These alterationswere reﬂected in a signiﬁcant increase in
aggregate size between days 10 and 15 (Fig. 4C). Additionally, the
co-culture aggregates were less compact, cellecell contacts were
decreased and cell polarity was lost in the surfaces of the lumens, as
indicated by ZO-1 translocation to the cytoplasm (Fig. 4D). In
contrast, the mono-cultures kept their initial phenotype
throughout the culture period.
Oestrogen Receptor (ER) and E-cadherin protein expression and
localisation in the aggregates were assessed by IHC and by WB
(Fig. 5). At day 5, the proportion of cells showing strong nuclear ER
staining was signiﬁcantly lower in the co-cultures compared to the
mono-cultures but did not reduce further over the culture period
(Fig. 5A). The proportion of tumour cells in the mono-cultures
showing strong ER staining intensity was reduced only after 15
days in culture. This reduction in strong ER staining was accompa-
nied by a signiﬁcant increase in cells showing moderate staining
intensity. The reduction in strong ER staining was also reﬂected in a
reduction of total ER protein, detectable byWB (Fig. 5A). E-cadherin
was present at the membrane in the majority of the cells in both
mono and co-cultures. To determine whether the level of mem-
branous E-cadherin expression altered throughout the culture
period, an image analysis algorithm was trained to recognise
staining at four threshold levels: weak, medium, strong and nega-
tive (Fig. 5B). Quantiﬁcation of membranous E-cadherin staining
revealed that, at day 5, the level of membranous E-cadherin was
similar in both mono- and co-cultures. In the mono-cultures how-
ever, E-cadherin localisation at the membrane increased over time
as indicated by a signiﬁcant increase in strong membranous stain-
ing, and a concomitant decrease in moderate membranous staining
(Fig. 5B). In contrast, in the co-cultures, membranous E-cadherin
was reduced at day 15, which is consistent with the observed
changes in polarity in the co-cultures over time (Fig. 4D). It is of note
that the inter-aggregate heterogeneity of E-cadherin staining by IHC
was higher than that observed for the ER.3.5. Tumour-stroma crosstalk within alginate microcapsules results
in a pro-inﬂammatory environment and increased angiogenic
response to MCF-7 cells
We next evaluated the production of cytokines in the micro-
encapsulated monocultures, as well as in co-cultures over time
(Fig. 6A and Supplementary ﬁgure S3). Mono-cultures of ﬁbroblasts
were used as controls. Supernatants from the extracellular fractions
Fig. 2. Phenotypic characterization of microencapsulated mono and co-cultures. (A) Live/dead assay (FDA e green; ToPro3 e blue, respectively) of MCF-7 (red) tumour ag-
gregates in mono and in co-culture with ﬁbroblasts, at day 5. (B) Tumour cell concentration proﬁle of mono and co-cultures along 15 days of culture; data are mean ± SD from four
independent experiments; ** indicate signiﬁcant difference with p < 0.003 by two way ANOVA statistics test. (C) Immunoﬂuorescence microscopy of alginate microcapsules in
10 mm thick cryosections, at day 5, show mono-culture and co-culture aggregates in the upper and lower panels, respectively. From the left: Cytokeratin 18 (CK18; green), b-Catenin
(green), Ki67 (green) and cleaved cytokeratin 18 (M30 cytodeath, red), f-actin (phalloidin; green), Zonula Occludens 1 (ZO-1, green) and DAPI (blue). (C1), (C2) and (C3) High
magniﬁcation insets represent the regions indicated by the white squares. The white arrow indicates the pyknotic nuclei. Scale bars: 50 mm, 10 mm for high-magniﬁcation inset (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.).
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tion (MSF) were assayed for a panel of 36 cytokines.
Six cytokines were signiﬁcantly higher in the co-cultures
compared to the mono-cultures: Serpin-E1, CXCL1, IL8, IL6, IL1ra
and sICAM-1 (Fig. 6A). Of these, the latter 2 appeared to be spe-
ciﬁcally retained inside the alginate microcapsules (Fig. 6A). No
statistically signiﬁcant differences were observed between co-
cultures and ﬁbroblast control cultures (Figure S3).
Since CXCL1, IL8 and sICAM-1 are known to promote angio-
genesis [31e34], we analysed the impact of the co-culture system
on the angiogenic potential of tumour cells at day 15 using a
standard CAM assay. After removal of stromal cells, ECM and sol-
uble factors, tumour cell aggregates from both types of culturewere
inoculated on the top of the CAM and incubated for 3 days. The
results obtained show that the number of new blood vessels
induced by the aggregates derived from co-cultures was higher
than that induced by mono-cultures (Fig. 6B).
4. Discussion
Multiple attempts have been made in the last decade towards
the improvement of in vitro preclinical models for cancer research[6]. Despite these efforts, most of the available models still fail to
mimic several important aspects of the tumour microenvironment,
and do not reﬂect the complexity of human tumours [6,7]. In
addition, most in vitro experiments can only be carried out over
short culture periods which, clearly, does not allow examination of
longer term effects of the microenvironment or drug treatments on
disease progression [35].
In this work we have developed a new strategy for in vitro
reconstruction of tumour microenvironment complexity, using a
robust culture system that allows long-term culture with contin-
uous monitoring. This system uses alginate microencapsulation of
epithelial tumour cell aggregates either alone or together with
human ﬁbroblasts. Tumour-stroma crosstalk was achieved by
keeping cells in close proximity and by accumulation of ECM
components and soluble factors in the alginate microcapsules.
Culture progression over time could be evaluated due to the non-
destructive sampling offered by this culture system.
Our results demonstrate that in microencapsulated aggregates,
MCF-7 cells self-organized into tissue-like structures by establish-
ing cellecell contacts presumably via E-cadherin, by partial polar-
isation at the surface of multiple small lumina and inverse
polarisation at the outer rim of the aggregate. Pyknotic nuclei were
Fig. 3. Collagen accumulation within the stromal compartment. (A) Immunoﬂuorescence microscopy of whole mount microencapsulated co-cultures of MCF-7 aggregates (red)
and ﬁbroblasts (vimentin e green), at day 5e 3D volume rendering of light sheet microscope (SPIM) images. (B) Number of ﬁbroblasts permicrocapsule, in co-cultures, at days 5 and
15 e images acquired by light sheet microscopy (SPIM); quantiﬁcation method described in Ref. [21]. (C) Immunoﬂuorescence microscopy of collagen I (green) in whole mount
microencapsulated MCF-7 aggregates (red) and ﬁbroblasts (blue), at day 5 emaximum intensity z-projection of 125 optical sections with 2 mm z-step by 2-photon microscopy. (C1)
High magniﬁcation inset represents the region indicated by the white square. The white arrow indicates the collagen I ﬁbres. (D) Total collagen quantiﬁcation of mono and co-
cultures, at days 5 and 15; data are mean ± SD from three independent experiments; * or þ indicate signiﬁcant difference with p < 0.01 by non-parametric KruskaleWallis
statistics test (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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cell death and subsequent cavitation [36]. These features together
with the relatively limited proliferative capacity are reminiscent of
well differentiated human breast tumours of the luminal subtype
or, indeed, the normal human breast epithelium [37,38]. The
absence of myoepithelial cells with a resulting lack of basement
membrane [39] may have contributed to the observed inverse
polarity seen at the rims of the aggregates [40]. However, inverse
polarity has also been described to occur in vivo, during tumori-
genesis [41]. Therefore, we could recapitulate certain features of
epithelial carcinomas such as breast by combining 3D aggregates
with alginate microencapsulation. Other groups have shown that
MCF-7 cells can polarise and maintain the luminal epithelial
phenotype but only when cultured in Matrigel for 7 days [9] or in
very long culture times in scaffold-free conditions (155 days) [42].
Similarly, we have also demonstrated that MCF-7 cells are unable to
polarise when cultured over 5 days without scaffolds (i.e. non-
microencapsulated), in our stirred-tank culture system although
the luminal-epithelial phenotype was maintained (Figure S1).
Overall our results demonstrate that aggregate microencapsulation
in alginate, an inert scaffold, allows cell movement required for
lumen formation and cell polarisation [37], by day 5 of culture.
We hypothesised that alginate entrapment of tumour cell ag-
gregates together with human ﬁbroblasts would further help
reconstruction of the different aspects of the tumour microenvi-
ronment. Our results show the differential distribution of tumour
and stromal cells. Epithelial tumour aggregates appear surrounded
by ﬁbroblasts, creating appropriately oriented “epithelial tumour”
and “stromal” compartments within the alginate microcapsules. In
contrast, when culturedwithout a scaffold, ﬁbroblasts accumulated
in the centre of the aggregates forming a core, as shown by us [26]
and by others [43,44]. In cultures without scaffolds, the ﬁbroblasts
remained viable and maintained collagen expression, however the
cellular organization did not resemble the human tumours whereepithelial and stromal cells are organized into distinct compart-
ments [3].
Imaging and quantiﬁcation of collagenwithin themicrocapsules
demonstrated a signiﬁcant increase of collagen deposition over the
time in the co-cultures, suggesting that ﬁbroblasts were playing
their biologic role by actively producing collagen [45]. Furthermore,
collagen type I appeared to be assembled into ﬁbres within the
stromal compartment, as typically observed in breast tissues
[46,47]. Collagen is the major component of human breast stroma
[48] and it is though that mammary epithelial cells migrate along
type I collagen ﬁbres during branching morphogenesis and tumour
cell dissemination [49,50]. Additionally, other studies have shown
that stiffer collagen matrices may promote mammary tumour cell
dissemination [49,51]. Accordingly, many 3D tumour models have
been developed using collagen type I matrices in order to deter-
mine the impact on tumour behaviour [2,6]. However, cell growth
and migration is dependent on collagen physical properties, which,
in turn, are greatly dependent on the type of cross-linking used
[52]. For this reason, the de novo synthesis of collagen by stromal
cells and its accumulation within the stromal compartment is a
major advantage of the alginate microencapsulated culture system.
To further understand the role played by ﬁbroblasts in our cul-
ture system, analysis of the proﬁle of cytokines produced at early
and late time points was carried out using cytokine arrays. Overall
the results indicate increased secretion of pro-inﬂammatory cyto-
kines, such as, IL6, IL8 and CXCL1 in the co-cultures. These pro-
inﬂammatory cytokines have been linked with increased tumour
aggressiveness, cell dissemination and angiogenesis [32]. Para-
doxically, an anti-inﬂammatory cytokine (IL1ra) was also increased
in the co-cultures. The reason for this is unclear but may be an
intrinsic feedback mechanism that limits the effects of pro-
inﬂammatory cytokines. Nevertheless, the overall balance of cyto-
kines suggests a pro-inﬂammatory environment in the co-cultures.
Furthermore, sICAM, a cytokine associatedwith tumour cell growth
Fig. 4. Phenotypic characterization of long-term (up to 15 days) microencapsulated mono and co-cultures. (A) Immunoﬂuorescence microscopy of whole mount micro-
encapsulated MCF-7 aggregates (red) with or without ﬁbroblasts (anti-vimentin e green), at day 15 e 3D volume rendering was carried out on images acquired with light sheet
microscopy (SPIM); Morphologic analysis of approximately 100 aggregates from mono and co-cultures e images acquired using SPIM. (B) Live/dead assay (FDA e green; ToPro3 e
blue, respectively) of MCF-7 (red) tumour aggregates in mono and in co-culture, at day 15. (C) Size distribution plot: aggregate surface area from mono and co-cultures, at days 2, 5,
10 and 15; data are mean ± SD from three independent experiments; *** and þþþ indicate signiﬁcant difference with p < 0.0001 by the non-parametric KruskaleWallis statistics
test. (D) Immunoﬂuorescence microscopy of alginate microcapsules 10 mm thick cryosections, at day 15, showmono-culture and co-culture aggregates in the in the upper and lower
panel, respectively. From the left: Cytokeratin 18 (CK18; green), b-Catenin (green), Ki67 (green) and cleaved cytokeratin 18 (M30 cytodeath, red), f-actin (phalloidin; green), Zonula
Occludens 1 (ZO-1, green) and DAPI (blue). (D1) High magniﬁcation inset represents the region indicated by the white square. Scale bars: 50 mm, 10 mm for high-magniﬁcation inset
(For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.).
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accumulated in the alginate microcapsule. It is well known that a
shift in the cytokine balance from an anti- to a pro-inﬂammatory
environment may lead to chronic inﬂammation that consequently
promotes tumour progression [53,54]. Our results recapitulate this
inﬂammatory shift, which strengthens our model as a good alter-
native to study tumour-stroma crosstalk mechanisms.
The non-destructive sampling allowed us to continuously
monitor the effect of the reconstructed microenvironment on cul-
ture progression throughout the culture time. By day 15, tumour
aggregates in co-cultures had an altered phenotype that was notobserved in mono-cultures. Analysis of aggregate morphology by
SPIM-FLUIDmicroscopy [21] demonstrated that approximately 40%
of the aggregates in co-culture had become irregular in shape and
had lost their circularity. In contrast 90% of the aggregates in the
mono-cultures retained their circularity. This change in shape in
the co-cultures resulted in increased aggregate surface area and
was accompanied by aggregate cell migration out of the micro-
capsules. The directionality of aggregate migration accompanied by
the stabilization of tumour cell concentration, is suggestive of an
event of collective cell migration rather than the cell movement
associated with expansive cell growth [50]. Ductal elongation, such
Fig. 5. Molecular characterization of ER and E-cadherin in long-term (day 15) microencapsulated mono and co-cultures. (A) Immunohistochemistry staining of 3 mm thick
parafﬁn sections of alginate microcapsules taken at days 5 and 15, show mono-culture and co-culture aggregates stained with (A) Oestrogen Receptor (ER); and (B) E-cadherin, and
respective quantiﬁcation of nuclear ER and membranous E-cadherin. (B1) and (B2) High magniﬁcation inset represents the region indicated by the black square. ER quantiﬁcation by
Western Blot from total protein extracts. Data are mean ± SD from two independent experiments; * indicate signiﬁcant difference with p < 0.01* and ***or þþþ indicate signiﬁcant
difference with p < 0.0001, both by a two way ANOVA statistics test. Scale bar: 50 mm (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the
web version of this article.).
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directional collective migration process [37], which might explain
the observed directionality in aggregate migration from the mi-
crocapsules. The accumulation of collagen exclusively in the stro-
mal compartment of co-cultures might be enough to stimulate
collective tumour cell migration. Furthermore, collective cell
migration typically occurs in carcinomas and has been described as
a crucial step in the disease progression towards metastatic cancer
[55].
The altered aggregate morphology and loss of cell polarity,
observed at day 15 in co-cultures, appears to be heralded by
reduced nuclear expression of ER which could be seen as early as
day 5 of co-culture compared to the aggregates in mono-culture.
The reasons underlying this early reduction in ER expression are
not, as yet, known but we speculate that reduction of signalling
through this receptor may be necessary before other phenotypic
changes can occur. Nuclear ER expression also declined in the
mono-cultures but at a much slower rate and was only apparentafter 15 days of culture. It is possible that the aggregates in the
mono-cultures would also have undergone a change in behaviour
and phenotype similar to that seen in the co-cultures if they had
been maintained in culture for long enough. This difference be-
tween mono and co-culture suggests that ﬁbroblasts are acceler-
ating ER depletion, as previously demonstrated by others [56]. ERþ
breast cancers are described to present high frequency of disease
relapse associated with metastasis and drug resistance, despite an
initial response to endocrine therapy [27,28]. Loss of hormone de-
pendency accompanied by altered sub-cellular localization of E-
cadherin and altered cell polarity have been described as common
features of more aggressive and invasive breast cancers [57e59].
Quantiﬁcation of membranous E-cadherin revealed a very high
percentage of aggregate heterogeneity in co-cultures compared to
mono-cultures, which was similar to the heterogeneity in aggre-
gate circularity, although the correlation between these two pa-
rameters has not been addressed. The reduction in E-cadherin
membrane staining could contribute to the observed loss of
Fig. 6. Characterization of the inﬂammatory environment and angiogenic potential of tumour cells microencapsulated in co-cultures. (A) Cytokine arrays of mono and co-
cultures from days 5 and 15, were performed for both culture and capsule supernatant. Data are mean ± SD from two independent experiments. * or þ indicate signiﬁcant difference
with p < 0.01 by a non-parametric Man-Whitney U statistics Test (two-tailed p-value). Microencapsulated mono-cultures of ﬁbroblasts were used as controls. (B) Quantiﬁcation and
representative images of Chick Chorioallantoic Membrane (CAM) Assays of tumour aggregates from both mono and co-cultures, at day 15. Vessels with less than 15 mm of diameter,
growing in a wheel shape manner towards the inoculation area, were quantiﬁed as newly formed vessels. Data are mean ± SD from 18 eggs. ** indicate signiﬁcant difference with
p < 0.001 by a t- Test (two-tailed p-value).
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observed in co-cultures is critical, since it may recapitulate the
intra-tumour heterogeneity observed in human tumours [50].
The angiogenic potential of both mono and co-cultures was
analysed by Chick Chorioallantoic Membrane (CAM) assay. Our
results demonstrate that, by day 15, tumour aggregates from co-
cultures have a higher capacity to induce angiogenesis, which
was indicated by the signiﬁcant increase in the number of new
radial blood vessels formed towards the aggregates from co-
cultures, when compared to those from mono-cultures. This in-
crease might be related to the increased expression of pro-
angiogenic cytokines in co-cultures, such as CXCL1 and IL8 in the
co-cultures [31e33]. Overall, our results show that tumour cells
were indeed educated by the stroma, since the new blood vessels
formed in the CAM assay were induced only by those tumour cells
that had been cultured for 15 days within the reconstructed tumour
microenvironment.
In conclusion, we have developed a robust and versatile model
system for long-term in vitro recapitulation of tumour-stroma
crosstalk, via reconstruction of key aspects of the tumour micro-
environment such as de novo synthesis and accumulation of ECMand cytokines, and allowing continuous monitoring of tumour
progression events in vitro. Entrapment of tumour cells and ﬁbro-
blasts in an inert scaffold allowed de novo synthesis and deposition
of ECM by the cells, and the accumulation of soluble factors, pro-
moting tumour-stroma crosstalk. This model system is trans-
ferrable to other types of tumour cells and provides a new tool for
further understanding tumour progression and drug resistance
mechanisms using either cell lines or patient-derived primary
cultures. In addition, it is easily transferable to industry for feeding
high-throughput systems or miniaturised bioreactors used for drug
development and target validation.
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